Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.
Authors
Davies, Mary-AnnKeiser, Olivia
Technau, Karl
Eley, Brian
Rabie, Helena
van Cutsem, Gilles
Giddy, Janet
Wood, Robin
Boulle, Andrew
Egger, Matthias
Moultrie, Harry
Affiliation
School of Public Health and Family Medicine, University of Cape Town. Mary-Ann.Davies@uct.ac.zaIssue Date
2009-10
Metadata
Show full item recordAbstract
OBJECTIVES: To assess paediatric antiretroviral treatment (ART) outcomes and their associations from a collaborative cohort representing 20% of the South African national treatment programme. DESIGN AND SETTING: Multi-cohort study of 7 public sector paediatric ART programmes in Gauteng, Western Cape and KwaZulu-Natal provinces. SUBJECTS: ART-naive children (< or = 16 years) who commenced treatment with > or = 3 antiretroviral drugs before March 2008. OUTCOME MEASURES: Time to death or loss to follow-up were assessed using the Kaplan-Meier method. Associations between baseline characteristics and mortality were assessed with Cox proportional hazards models stratified by site. Immune status, virological suppression and growth were described in relation to duration of ART. RESULTS: The median (interquartile range) age of 6 078 children with 9 368 child-years of follow-up was 43 (15 - 83) months, with 29% being < 18 months. Most were severely ill at ART initiation. More than 75% of children were appropriately monitored at 6-monthly intervals with viral load suppression (< 400 copies/ml) being 80% or above throughout 36 months of treatment. Mortality and retention in care at 3 years were 7.7% (95% confidence interval 7.0 - 8.6%) and 81.4% (80.1 - 82.6%), respectively. Together with young age, all markers of disease severity (low weight-for-age z-score, high viral load, severe immune suppression, stage 3/4 disease and anaemia) were independently associated with mortality. CONCLUSIONS: Dramatic clinical benefit for children accessing the national ART programme is demonstrated. Higher mortality in infants and those with advanced disease highlights the need for early diagnosis of HIV infection and commencement of ART.PubMed ID
20128272Language
enISSN
0256-9574Collections
Related articles
- Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration.
- Authors: Cornell M, Technau K, Fairall L, Wood R, Moultrie H, van Cutsem G, Giddy J, Mohapi L, Eley B, MacPhail P, Prozesky H, Rabie H, Davies MA, Maxwell N, Boulle A, International epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration.
- Issue date: 2009 Sep
- Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa.
- Authors: Grimwood A, Fatti G, Mothibi E, Malahlela M, Shea J, Eley B
- Issue date: 2012 May 31
- Successful paediatric HIV treatment in rural primary care in Africa.
- Authors: Janssen N, Ndirangu J, Newell ML, Bland RM
- Issue date: 2010 Jun
- Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort.
- Authors: Jesson J, Koumakpaï S, Diagne NR, Amorissani-Folquet M, Kouéta F, Aka A, Lawson-Evi K, Dicko F, Kouakou K, Pety T, Renner L, Eboua T, Coffie PA, Desmonde S, Leroy V, Paediatric WADA IeDEA Collaboration.
- Issue date: 2015 Jul
- Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort study.
- Authors: Fatti G, Bock P, Grimwood A, Eley B
- Issue date: 2010 Nov 25